Page 26 - Moleculin Biotech Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Moleculin biotech inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Moleculin Biotech Inc Today - Breaking & Trending Today

Moleculin Biotech (NASDAQ:MBRX) Now Covered by StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Rating) in a report released on Tuesday. The firm set a “sell” rating on the stock. MBRX has been the topic of a number of other reports. Oppenheimer reiterated an “outperform” rating and set a $5.00 target price on shares of […] ....

Roth Mkm , Charles Schwab Investment Management Inc , Renaissance Technologies , Moleculin Biotech Inc , Moleculin Biotech , Get Rating , Schwab Investment Management , State Street Corp , Street Corp , Moleculin Biotech Daily , Nasdaq Mbrx , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)

StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Rating) in a report released on Monday. The brokerage issued a sell rating on the stock. MBRX has been the topic of a number of other research reports. Oppenheimer reaffirmed an outperform rating and set a $5.00 price objective on shares of Moleculin Biotech […] ....

United States , Roth Mkm , Walterv Klemp , Moleculin Biotech Inc , Renaissance Technologies , Charles Schwab Investment Management Inc , Moleculin Biotech , Get Rating , Street Corp , Charles Schwab Investment Management , Waldemar Priebe , Moleculin Biotech Daily , Nasdaq Mbrx , Initiated Coverage , Stocknews Com ,

Moleculin Announces Adjournment of 2023 Annual Meeting to June 15, 2023

/PRNewswire/ Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a growing pipeline,. ....

United States , Jenene Thomas , Walter Klemp , Prnewswire Moleculin Biotech Inc , Moleculin Biotech Inc , Annual Meeting , Glass Lewis , Chief Executive Officer , Okapi Partners , Moleculin Biotech , Transcription Modulator ,

Enzyme Trading 3% Lower Over Last 7 Days (MLN)

StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Rating) in a research report report published on Sunday. The brokerage issued a sell rating on the stock. MBRX has been the subject of a number of other reports. Roth Mkm reaffirmed a buy rating and set a $16.00 price target on shares of […] ....

United States , Walterv Klemp , Roth Mkm , Renaissance Technologies , Moleculin Biotech Company Profile , Moleculin Biotech Inc , Charles Schwab Investment Management Inc , Moleculin Biotech , Get Rating , Schwab Investment Management , State Street Corp , Street Corp , Waldemar Priebe , Moleculin Biotech Daily , Nasdaq Mbrx , Initiated Coverage , Stocknews Com ,

Moleculin Biotech (NASDAQ:MBRX) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Rating) in a research report report published on Sunday morning. The firm issued a sell rating on the stock. A number of other brokerages also recently issued reports on MBRX. Roth Mkm reiterated a buy rating and issued a $16.00 price target on shares […] ....

United States , Roth Mkm , Walterv Klemp , Charles Schwab Investment Management Inc , Moleculin Biotech Inc , Renaissance Technologies , Moleculin Biotech , Get Rating , Schwab Investment Management , State Street Corp , Street Corp , Waldemar Priebe , Moleculin Biotech Daily , Nasdaq Mbrx , Initiated Coverage , Stocknews Com ,